Cybp as a marker for lung cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2761873

The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.

La présente invention concerne l'évaluation du cancer du poumon et l'utilisation de la protéine CYBP dans l'évaluation du cancer du poumon. L'invention concerne également un procédé d'évaluation du cancer du poumon in vitro à l'aide d'un échantillon liquide, provenant d'un individu, par la mesure de CYBP dans ledit échantillon. La mesure de CYBP peut, par exemple, être utilisée dans la détection précoce ou dans le suivi de patients atteints du cancer du poumon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cybp as a marker for lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cybp as a marker for lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cybp as a marker for lung cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1921517

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.